Published in Nurs Res on May 17, 2005
Management trends in prenatally detected hydronephrosis: national survey of pediatrician practice patterns and antibiotic use. Urology (2011) 1.49
Lottery-based versus fixed incentives to increase clinicians' response to surveys. Health Serv Res (2011) 1.14
Web-based versus traditional paper questionnaires: a mixed-mode survey with a Nordic perspective. J Med Internet Res (2013) 1.09
Surveying multiple health professional team members within institutional settings: an example from the nursing home industry. Eval Health Prof (2014) 0.95
Nurse Practitioners' attitudes about cancer clinical trials and willingness to recommend research participation. Contemp Clin Trials (2011) 0.95
Developing a Model of the Benefits and Burdens of Research Participation in Cancer Clinical Trials. AJOB Prim Res (2012) 0.95
Achieving a high response rate with a health care provider survey, Washington State, 2006. Prev Chronic Dis (2010) 0.89
Surgical management of stress urinary incontinence in women: safety, effectiveness and cost-utility of trans-obturator tape (TOT) versus tension-free vaginal tape (TVT) five years after a randomized surgical trial. BMC Womens Health (2011) 0.86
An assessment of incentive versus survey length trade-offs in a Web survey of radiologists. J Med Internet Res (2013) 0.85
A randomized trial of the impact of survey design characteristics on response rates among nursing home providers. Eval Health Prof (2011) 0.83
Survey Methods to Optimize Response Rate in the National Dental Practice-Based Research Network. Eval Health Prof (2016) 0.83
Can incentives undermine intrinsic motivation to participate in epidemiologic surveys? Eur J Epidemiol (2010) 0.81
Establishing good collaborative research practices in the responsible conduct of research in nursing science. Nurs Outlook (2014) 0.75
The effect of a monetary incentive for administrative assistants on the survey response rate: a randomized controlled trial. BMC Med Res Methodol (2016) 0.75
Determinants of practice patterns in pediatric UTI management. J Pediatr Urol (2016) 0.75
The limitations of "vulnerability" as a protection for human research participants. Am J Bioeth (2004) 14.06
What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis (2004) 9.65
Association between critical care physician management and patient mortality in the intensive care unit. Ann Intern Med (2008) 9.21
Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med (2005) 8.25
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother (2008) 6.55
Views of US physicians about controlling health care costs. JAMA (2013) 6.36
Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med (2004) 5.47
Dealing with the long-term social implications of research. Am J Bioeth (2011) 5.41
How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question. J Natl Cancer Inst (2009) 5.40
Does ethics education influence the moral action of practicing nurses and social workers? Am J Bioeth (2008) 4.92
Comparison of "B" readers' interpretations of chest radiographs for asbestos related changes. Acad Radiol (2004) 4.71
Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med (2003) 4.46
The accuracy of surrogate decision makers: a systematic review. Arch Intern Med (2006) 4.17
Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. IRB (2003) 3.82
Enduring and emerging challenges of informed consent. N Engl J Med (2015) 3.79
Clinical trials and medical care: defining the therapeutic misconception. PLoS Med (2007) 3.77
Descriptions of benefits and risks in consent forms for phase 1 oncology trials. N Engl J Med (2002) 3.62
Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med (2004) 3.58
Development in infants with autism spectrum disorders: a prospective study. J Child Psychol Psychiatry (2006) 3.54
SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infect Control Hosp Epidemiol (2010) 3.44
Enhancing patient-centered communication and collaboration by using the electronic health record in the examination room. JAMA (2013) 3.44
Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders. Arch Gen Psychiatry (2007) 3.29
Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer. J Clin Oncol (2007) 3.23
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol (2014) 3.20
Patients' decision-making process regarding participation in phase I oncology research. J Clin Oncol (2006) 2.72
End-of-life care for the critically ill: A national intensive care unit survey. Crit Care Med (2006) 2.61
Informed Consent. N Engl J Med (2017) 2.56
Quality indicators for end-of-life care in the intensive care unit. Crit Care Med (2003) 2.42
A national survey of U.S. internists' experiences with ethical dilemmas and ethics consultation. J Gen Intern Med (2004) 2.27
Moral distress: a growing problem in the health professions? Hastings Cent Rep (2010) 2.23
Examining the ethics of clinical use of unproven interventions outside of clinical trials during the Ebola epidemic. Am J Bioeth (2015) 2.20
Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia. Clin Cancer Res (2005) 2.10
A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn. J Empir Res Hum Res Ethics (2011) 2.03
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood (2011) 2.03
Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee. Clin Cancer Res (2010) 1.93
More than the money: a review of the literature examining healthy volunteer motivations. Contemp Clin Trials (2010) 1.92
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis (2007) 1.91
Paying research subjects: an analysis of current policies. Ann Intern Med (2002) 1.90
Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer. Clin Cancer Res (2009) 1.85
The ethics of paying for children's participation in research. J Pediatr (2002) 1.80
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. J Urol (2007) 1.75
Participants in phase 1 oncology research trials: are they vulnerable? Arch Intern Med (2008) 1.74
Ethical climate, ethics stress, and the job satisfaction of nurses and social workers in the United States. Soc Sci Med (2007) 1.72
The invisible hand in clinical research: the study coordinator's critical role in human subjects protection. J Law Med Ethics (2002) 1.72
The quality of informed consent: mapping the landscape. A review of empirical data from developing and developed countries. J Med Ethics (2012) 1.69
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med (2012) 1.68
A framework for rationing by clinical judgment. Kennedy Inst Ethics J (2007) 1.67
Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med (2013) 1.66
Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) (2010) 1.65
Response to joint attention in toddlers at risk for autism spectrum disorder: a prospective study. J Autism Dev Disord (2007) 1.65
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res (2008) 1.62
Why patients continue to participate in clinical research. Arch Intern Med (2008) 1.62
A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia. Blood (2006) 1.59
Research on stored biological samples: the views of Ugandans. IRB (2005) 1.59
Risks of propofol sedation/anesthesia for imaging studies in pediatric research: eight years of experience in a clinical research center. Arch Pediatr Adolesc Med (2010) 1.59
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res (2006) 1.58
Prevalence and determinants of physician bedside rationing: data from Europe. J Gen Intern Med (2006) 1.57
Ethical considerations in HIV cure research: points to consider. Curr Opin HIV AIDS (2013) 1.55
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest (2011) 1.54
Choosing Healthplans All Together: a deliberative exercise for allocating limited health care resources. J Health Polit Policy Law (2005) 1.53
ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett (2010) 1.50
Will insured citizens give up benefit coverage to include the uninsured? J Gen Intern Med (2004) 1.49
Regional ethics organizations for protection of human research participants. Nat Med (2004) 1.48
Rationing in the intensive care unit. Crit Care Med (2006) 1.45
How can bedside rationing be justified despite coexisting inefficiency? The need for 'benchmarks of efficiency'. J Med Ethics (2012) 1.44
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes. Leuk Res (2008) 1.43
Development and validation of a printed information brochure for families of chronically critically ill patients. Crit Care Med (2012) 1.43
Capromab pendetide scanning has a potential role in optimizing patient selection for salvage cryosurgical ablation of the prostate. Urology (2010) 1.43
End-of-life care for terminally ill participants in clinical research. J Palliat Med (2002) 1.41
A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease. J Natl Cancer Inst (2007) 1.41
Deliberation to enhance awareness of and prioritize socioeconomic interventions for health. Soc Sci Med (2011) 1.40
Ductal access for prevention and therapy of mammary tumors. Cancer Res (2006) 1.38
Respondent burden in clinical research: when are we asking too much of subjects? IRB (2005) 1.37
Enrolling the uninsured in clinical trials: an ethical perspective. Crit Care Med (2003) 1.37
Clinical research with economically disadvantaged populations. J Med Ethics (2007) 1.36
Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin Cancer Res (2004) 1.35
Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors. J Clin Oncol (2008) 1.30
Comprehension and informed consent: assessing the effect of a short consent form. IRB (2010) 1.30
Including persons with HIV infection in cancer clinical trials. J Clin Oncol (2008) 1.30
Money, coercion, and undue inducement: attitudes about payments to research participants. IRB (2012) 1.29
Health insurance benefit packages prioritized by low-income clients in India: three criteria to estimate effectiveness of choice. Soc Sci Med (2006) 1.28
What should research participants understand to understand they are participants in research? Bioethics (2008) 1.27
Reciprocity and post-trial access for participants in antiretroviral therapy trials. AIDS (2006) 1.26
Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proc Natl Acad Sci U S A (2007) 1.22
Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. Cancer Biol Ther (2006) 1.19
Quality of parental consent in a Ugandan malaria study. Am J Public Health (2005) 1.19
A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion. PLoS One (2011) 1.17
Focus groups highlight that many patients object to clinicians' focusing on costs. Health Aff (Millwood) (2013) 1.16
K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate. Clin Cancer Res (2010) 1.15
Pharmacologic and toxicologic evaluation of C. novyi-NT spores. Toxicol Sci (2005) 1.14
Enrolling pregnant women: issues in clinical research. Womens Health Issues (2013) 1.13
Points to consider: The research ethics consultation service and the IRB. IRB (2009) 1.13
The quality of informed consent in a clinical research study in Thailand. IRB (2005) 1.13
Patient autonomy and the challenge of clinical uncertainty. Kennedy Inst Ethics J (2002) 1.13
Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma. Biol Blood Marrow Transplant (2006) 1.12
Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species. J Clin Microbiol (2012) 1.12
Views of adolescents and parents on pediatric research without the potential for clinical benefit. Pediatrics (2012) 1.11